Memory Assessment in Studies of Cognition-Enhancing Drugs for Alzheimer's Disease

By Simard M.   van Reekum R.  

Drugs & Aging, Vol. 14, Iss. 3, 1999-03 ,pp. : 197-230

Adis International

Access to resources Recommend Favorite

2-Pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs

By Scapecchi S.   Martelli C.   Ghelardini C.   Guandalini L.   Martini E.   Gualtieri F.  

Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. : 715-722

Elsevier

Access to resources Recommend Favorite

Plasma Metabolic Profiling of Mild Cognitive Impairment and Alzheimer's Disease Using Liquid Chromatography/Mass Spectrometry

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 14, Iss. 2, 2014-09 ,pp. : 113-120

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidant Clinical Trials in Mild Cognitive Impairment and Alzheimer’s disease – Challenges and Perspectives

By  

Current Pharmaceutical Design, Vol. 20, Iss. 18, 2014-06 ,pp. : 3083-3092

Bentham Science Publishers

Access to resources Recommend Favorite

White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies

By Radanovic Marcia   Pereira Fabrício Ramos Silvestre   Stella Florindo   Aprahamian Ivan   Ferreira Luiz Kobuti   Forlenza Orestes Vicente   Busatto Geraldo F  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 5, 2013-05 ,pp. : 483-493

Informa Healthcare

Access to resources Recommend Favorite